1. Home
  2. RELI vs NBY Comparison

RELI vs NBY Comparison

Compare RELI & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RELI
  • NBY
  • Stock Information
  • Founded
  • RELI 2013
  • NBY 2000
  • Country
  • RELI United States
  • NBY United States
  • Employees
  • RELI N/A
  • NBY N/A
  • Industry
  • RELI Specialty Insurers
  • NBY
  • Sector
  • RELI Finance
  • NBY
  • Exchange
  • RELI Nasdaq
  • NBY Nasdaq
  • Market Cap
  • RELI 4.0M
  • NBY 3.8M
  • IPO Year
  • RELI N/A
  • NBY 2007
  • Fundamental
  • Price
  • RELI $1.06
  • NBY $0.62
  • Analyst Decision
  • RELI
  • NBY Strong Buy
  • Analyst Count
  • RELI 0
  • NBY 1
  • Target Price
  • RELI N/A
  • NBY $0.85
  • AVG Volume (30 Days)
  • RELI 154.5K
  • NBY 44.5K
  • Earning Date
  • RELI 07-30-2025
  • NBY 08-14-2025
  • Dividend Yield
  • RELI N/A
  • NBY N/A
  • EPS Growth
  • RELI N/A
  • NBY N/A
  • EPS
  • RELI N/A
  • NBY 0.41
  • Revenue
  • RELI $14,061,478.00
  • NBY $9,781,000.00
  • Revenue This Year
  • RELI N/A
  • NBY $23.91
  • Revenue Next Year
  • RELI N/A
  • NBY $32.05
  • P/E Ratio
  • RELI N/A
  • NBY $1.55
  • Revenue Growth
  • RELI 1.07
  • NBY 113.47
  • 52 Week Low
  • RELI $0.91
  • NBY $0.44
  • 52 Week High
  • RELI $5.11
  • NBY $1.01
  • Technical
  • Relative Strength Index (RSI)
  • RELI 38.40
  • NBY 51.39
  • Support Level
  • RELI $1.02
  • NBY $0.57
  • Resistance Level
  • RELI $1.10
  • NBY $0.70
  • Average True Range (ATR)
  • RELI 0.08
  • NBY 0.04
  • MACD
  • RELI 0.01
  • NBY -0.00
  • Stochastic Oscillator
  • RELI 33.33
  • NBY 48.98

About RELI Reliance Global Group Inc.

Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: